By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



99 Hayden Avenue
Suite 390
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-357-2333 Fax: 781-357-2399



Company News
Advances in Inhaled Drug Delivery Offer Major Benefits To Patients, Chief Scientific Officer For Pulmatrix Explains In Article 4/19/2016 10:33:16 AM
Pulmatrix Reports 2015 Financial Results; Provides 2016 Outlook On Pulmonary Disease Pipeline 3/10/2016 8:03:47 AM
Pulmatrix To Present at 2016 Cowen and Company 36th Annual Healthcare Conference 3/4/2016 10:05:42 AM
CAPSUGEL And Pulmatrix Enter Collaboration To Develop And Manufacture Novel Inhaled Therapeutics 2/16/2016 9:34:16 AM
Pulmatrix Initiates European Pilot Bioequivalence Study Of PUR0200 For COPD 2/1/2016 6:50:18 AM
Pulmatrix To Present At Upcoming Investor Conferences 1/7/2016 10:47:46 AM
Pulmatrix To List On Nasdaq Global Market 12/18/2015 6:31:28 AM
Pulmatrix Reports 3rd Quarter Results; Provides Update On Business & Development Pipeline 11/12/2015 10:15:12 AM
Pulmatrix To Webcast Investor Presentation At Upcoming Investor Conferences 10/9/2015 7:52:50 AM
Study: Pulmatrix's PUR1900 Inhaled Cystic Fibrosis Drug Demonstrates High Lung Retention And Potency Against Fungal Infection 10/8/2015 6:24:56 AM